维普期刊资源整合服务平台（V6.5）

30篇 您的检索式：作者名="Wysham"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type2diabetes(DURATION-2):a randomised trial显示文摘	Bergenstal RM Wysham C Macconell L	2010	Lancet2010，376，9739：	1
2	Efficacy and safety of dulaglutide added onto pioglitazone and mefformin versus exena- tide in type 2 diabetes in a randomized controlled rrial (AWARD -1 )显示文摘	Wysham C Blevins T Arakaki R	2014	Diabetes Care2014，37，8：	1
3	Once weekly exenatide:efficacy,tolerability and place in therapy显示文摘	Wysham C Grimm M Chen S	2013	Diabetes Obes Metab2013，15，10：	1
4	Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exe- natide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD- 1 )显示文摘	Wysham C Blevins T Arakaki R	2014	Diabetes Care2014，37，8：	1
5	Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2) : a randomised trial显示文摘	BERGENSTAL R M WYSHAM C MACCONELL L	2010	Lancet2010，376，9739：	1
6	Efficacy andsafety of exenatide once weekly versus sitagliptin or pioglitazoneas an adjunct to metformin for treatment of type 2 diabetes ( DU-RATION-2) :a randomised trial 显示文摘	Bergenstal RM Wysham C Macconell L	2010	Lancet2010，376，43：	1
7	Effi- cacy and safety of exenatide once weekly versus sitagliptin or pio-glitazone as an adjunct to metfomlin for treatment of type 2 diabe- tes (DURATION-2) : A randomised trial显示文摘	BERGENSTAL R M WYSHAM C MACCONELL L	2010	Lancet2010，376，9739：	1
8	Effi- cacy and safety of exenatide once weekly versus sitagliptin or pio- glitazone as an adjunct to metformin for treatment of type 2 diabe- tes (DURATION-2) : A randomised trial显示文摘	BERGENSTAL RM WYSHAM C MACCONELL L	2010	Lancet2010，376，9739：	1
9	BRCAness profile of sporadic ovarian cancer predicts disease recurrence显示文摘	Wysham WZ Mhawech-Fauceglia P Li H		0，，01：	1
10	Efficacy andsafety of exenatide once weekly versus sitagliptin or pioglitazone asan adjunct to metformin for treatment of type 2 diabetes(DURA-TION-2):a randomised trial显示文摘	Bergenstal RM Wysham C Macconell L	2010	Lancet2010，376，9739：	1
11	Efficacy and safe- ty of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes ( DURATION- 2) : a randomised trial显示文摘	Bergenstal RM Wysham C Macconell L	2010	Lancet2010，376，9739：	1
12	Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2) : a randomised trial显示文摘	Bergenstal RM Wysham C Macconell L	2010	Lancet2010，376，9739：	1
13	Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to mefformin for treatment of type 2 diabetes (DURATION-2): a randomised trial显示文摘	Bergenstal RM Wysham C Macconell L	2010	Lancet2010，376，9739：	1
14	Efficacy and safety of dulaglutide added onto pioglitazone and metformin versus exenatide in type 2 diabetes in a randomized controlled trial ( A- WARD-I)显示文摘	WYSHAM C BLEVINS T ARAKAKI R	2014	Diabetes Care2014，37，8：	1
15	Symptom burden of chronic lung disease compared with lung cancer at time of referral for palliative care consuhation显示文摘	Wysham NG Cox CE Wolf SP	2015	Ann Am Thorac Soc2015，12，9：	1
16	Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type2diabetes(DURATION-2):a randomised trial显示文摘	Bergenstal RM Wysham C Macconell L	2010	Lancet2010，376，9739：	1
17	Efficacy and safety of dulaglutide added onto pioglitazone and metformin versus exenatide in type 2 diabetes in a randomized controlled trial( A-WARD-I) 显示文摘	WYSHAM C BLEVINS T ARAKAKI R	2014	Diabetes Care2014，37，8：	1
18	Regime shifts in ecological systems can occur with no warning显示文摘	Hastings A Wysham D B	2010	Ecology Letters2010，13，4：	1
19	Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DU- RATION-2): a randomised trial显示文摘	Bergenstal RM Wysham C Macconell L	2010	Lancet2010，376，9739：	1
20	Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes(DURATION-2):a randomised trial显示文摘	Bergenstal RM Wysham C Macconell L		0，，9739：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示